» Articles » PMID: 9770539

Human Milk Lactoferrin Inactivates Two Putative Colonization Factors Expressed by Haemophilus Influenzae

Overview
Specialty Science
Date 1998 Oct 15
PMID 9770539
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Haemophilus influenzae is a major cause of otitis media and other respiratory tract disease in children. The pathogenesis of disease begins with colonization of the upper respiratory mucosa, a process that involves evasion of local immune mechanisms and adherence to epithelial cells. Several studies have demonstrated that human milk is protective against H. influenzae colonization and disease. In the present study, we examined the effect of human milk on the H. influenzae IgA1 protease and Hap adhesin, two autotransported proteins that are presumed to facilitate colonization. Our results demonstrated that human milk lactoferrin efficiently extracted the IgA1 protease preprotein from the bacterial outer membrane. In addition, lactoferrin specifically degraded the Hap adhesin and abolished Hap-mediated adherence. Extraction of IgA1 protease and degradation of Hap were localized to the N-lobe of the bilobed lactoferrin molecule and were inhibited by serine protease inhibitors, suggesting that the lactoferrin N-lobe may contain serine protease activity. Additional experiments revealed no effect of lactoferrin on the H. influenzae P2, P5, and P6 outer-membrane proteins, which are distinguished from IgA1 protease and Hap by the lack of an N-terminal passenger domain or an extracellular linker region. These results suggest that human milk lactoferrin may attenuate the pathogenic potential of H. influenzae by selectively inactivating IgA1 protease and Hap, thereby interfering with colonization. Future studies should examine the therapeutic potential of lactoferrin, perhaps as a supplement in infant formulas.

Citing Articles

Lactoferrin impairs pathogen virulence through its proteolytic activity.

Ongena R, Dierick M, Vanrompay D, Cox E, Devriendt B Front Vet Sci. 2024; 11:1428156.

PMID: 39176399 PMC: 11339958. DOI: 10.3389/fvets.2024.1428156.


Potential of Lactoferrin in the Treatment of Lung Diseases.

Kaczynska K, Jampolska M, Wojciechowski P, Sulejczak D, Andrzejewski K, Zajac D Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259341 PMC: 9960651. DOI: 10.3390/ph16020192.


Hindrance of the Proteolytic Activity of Neutrophil-Derived Serine Proteases by Serine Protease Inhibitors as a Management of Cardiovascular Diseases and Chronic Inflammation.

Burster T, Mustafa Z, Myrzakhmetova D, Zhanapiya A, Zimecki M Front Chem. 2021; 9:784003.

PMID: 34869231 PMC: 8634265. DOI: 10.3389/fchem.2021.784003.


Bovine apo-lactoferrin affects the secretion of proteases in A2.

Ramirez-Rico G, Martinez-Castillo M, Avalos-Gomez C, de la Garza M Access Microbiol. 2021; 3(10):000269.

PMID: 34816089 PMC: 8604176. DOI: 10.1099/acmi.0.000269.


Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides.

Gruden S, Poklar Ulrih N Int J Mol Sci. 2021; 22(20).

PMID: 34681923 PMC: 8541349. DOI: 10.3390/ijms222011264.


References
1.
Levay P, Viljoen M . Lactoferrin: a general review. Haematologica. 1995; 80(3):252-67. View

2.
Anderson P, JOHNSTON Jr R, Smith D . Human serum activities against Hemophilus influenzae, type b. J Clin Invest. 1972; 51(1):31-8. PMC: 332925. DOI: 10.1172/JCI106793. View

3.
BAKER H, Day C, Norris G, Baker E . Enzymatic deglycosylation as a tool for crystallization of mammalian binding proteins. Acta Crystallogr D Biol Crystallogr. 1994; 50(Pt 4):380-4. DOI: 10.1107/S0907444993013435. View

4.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

5.
Hendrixson D, de la Morena M, Stathopoulos C, St Geme 3rd J . Structural determinants of processing and secretion of the Haemophilus influenzae hap protein. Mol Microbiol. 1997; 26(3):505-18. DOI: 10.1046/j.1365-2958.1997.5921965.x. View